Towia Aron Libermann, Ph.D.
Title Associate Professor of Medicine Institution Beth Israel Deaconess Medical Center Address Beth Israel Deaconess Medical Center Research North Building, Room 380C 99 Brookline Ave Boston MA 02215
|
|
Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
R21CA218960
(LIBERMANN, TOWIA A.)
Jul 17, 2018 - Jun 30, 2021
Identification of Plasma- and Exosome-Based Protein Biomarkers for Early Detection of Pancreatic Cancer Using SOMAscan Technology
Role: Principal Investigator
-
R01AG051658
(MARCANTONIO, EDWARD R)
Jan 15, 2016 - Dec 31, 2020
Advancing the Understanding of Postoperative Delirium Mechanisms via Multi-Omics
Role: Principal Investigator
-
R21CA187843
(LIBERMANN, TOWIA A.)
Jun 12, 2015 - May 31, 2017
Role of Axl in docetaxel resistance in prostate cancer
Role: Principal Investigator
-
R21CA176912
(LIBERMANN, TOWIA A.)
Apr 15, 2013 - Jul 31, 2015
Novel treatment strategies for enhancing sunitinib response in renal cell cancer
Role: Principal Investigator
-
R21CA107352
(LIBERMANN, TOWIA A)
May 1, 2005 - Apr 30, 2008
NOVEL APPROACHES TO GENE PROFILING IN OVARIAN CANCER
Role: Principal Investigator
-
P01HL076540
(AIRD, WILLIAM C)
Jul 1, 2004 - Jul 31, 2016
Endothelial Cell Phenotypes in Health and Disease
Role: Co-Principal Investigator
-
P01CA092644
(DVORAK, HAROLD FISHER)
Jul 1, 2001 - Sep 30, 2015
Spatial and Temporal Regulation of Angiogenesis
Role: Co-Principal Investigator
-
R01AI049527
(LIBERMANN, TOWIA A)
May 1, 2001 - Mar 31, 2006
Ese-1, a New Transcriptional Mediator of Inflammation
Role: Principal Investigator
-
R01CA085467
(LIBERMANN, TOWIA A)
Apr 1, 2001 - Mar 31, 2006
ROLE OF A NEW ETS FACTOR, PDEF, IN PROSTATE CANCER
Role: Principal Investigator
-
U24DK058739
(LIBERMANN, TOWIA A)
Sep 30, 2000 - Aug 31, 2003
NIDDK BIOTECHNOLOGY CENTER
Role: Principal Investigator
-
R01CA076323
(LIBERMANN, TOWIA A)
May 1, 1999 - Feb 29, 2004
NEW ETS FACTOR, ESE-1, AND EPITHELIAL CELLS
Role: Principal Investigator
-
P01CA072009
(TENEN, DANIEL G)
Sep 15, 1997 - Apr 30, 2008
INTERACTING FACTORS IN HEMATOPOIESIS AND LEUKEMIA
Role: Co-Principal Investigator
-
R01DK052019
(LIBERMANN, TOWIA A)
Sep 15, 1997 - Aug 31, 2001
GENE TRANSFER APPROACH TO PREVENT TRANSPLANT REJECTION
Role: Principal Investigator
-
P01AI041521
(TURKA, LAURENCE A)
Aug 1, 1997 - Dec 31, 2012
Costimulation and Cytokines in Tolerance
Role: Co-Principal Investigator
-
R01AI039613
(LIBERMANN, TOWIA A)
Dec 15, 1996 - Sep 14, 1997
FUNCTION OF ELF-1 AND A NOVEL ETS FACTOR NERF IN B CELLS
Role: Principal Investigator
-
R01AI033211
(LIBERMANN, TOWIA A)
Apr 1, 1992 - Mar 31, 1997
B-CELL DEVELOPMENT--ROLE OF TRANSCRIPTIONAL REGULATORS
Role: Principal Investigator
-
P30CA006516
(GLIMCHER, LAURIE HOLLIS)
Nov 30, 2026
Dana-Farber/Harvard Cancer Center
Role: Co-Principal Investigator
Bibliographic
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.